1. Home
  2. PLRX vs SWBI Comparison

PLRX vs SWBI Comparison

Compare PLRX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.13

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$13.52

Market Cap

637.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLRX
SWBI
Founded
2015
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
637.4M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
PLRX
SWBI
Price
$1.13
$13.52
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$2.67
$14.00
AVG Volume (30 Days)
377.1K
599.4K
Earning Date
05-06-2026
06-17-2026
Dividend Yield
N/A
3.37%
EPS Growth
29.97
36.67
EPS
N/A
0.06
Revenue
N/A
$523,845,000.00
Revenue This Year
N/A
$7.61
Revenue Next Year
N/A
$3.72
P/E Ratio
N/A
$222.17
Revenue Growth
N/A
10.36
52 Week Low
$1.02
$8.14
52 Week High
$1.95
$17.56

Technical Indicators

Market Signals
Indicator
PLRX
SWBI
Relative Strength Index (RSI) 48.97 50.89
Support Level $1.11 $12.09
Resistance Level $1.21 $14.32
Average True Range (ATR) 0.05 0.51
MACD -0.00 0.11
Stochastic Oscillator 43.48 69.88

Price Performance

Historical Comparison
PLRX
SWBI

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based company engaged in manufacturing and selling firearms. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The company sells its products under the Smith and Wesson and Gemtech brands, which are used for defense, law enforcement, hunting, and sporting purposes. Geographically, it sells products globally, with maximum income being generated by the U.S. market from its handgun products.

Share on Social Networks: